• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (COVINGTON) -1018233 BARD® INLAY® URETERAL STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (COVINGTON) -1018233 BARD® INLAY® URETERAL STENT Back to Search Results
Model Number 778426
Device Problem Calcified (1077)
Patient Problems Fever (1858); Chills (2191); Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Date 08/08/2022
Event Type  Injury  
Manufacturer Narrative
The investigation is still in progress.Once the investigation is complete a supplemental report will be filed.
 
Event Description
It was reported that the patient underwent right ureteroscopic right ureteral lithotripsy on (b)(6) 2021, and a right ureteral stent was placed during the operation.On (b)(6) 2022, the right ureteral stent was removed by cystoscopy.The stent tube could not be pulled out after half of the stent tube was pulled out.The stent tube was found to have stones and floccules under the microscope, and the extubation was stopped, and the hospitalization procedures were completed.It was planned to sent the patient to the operating room for ureteral lithotripsy and stent removal.At 8:00 on (b)(6), the patient developed chills and high fever.The symptoms did not improve after anti-infective treatment and fluid replacement therapy, and the operation was suspended.At 17:54 on (b)(6), the patient developed septic shock.After active rescue and treatment, there was no significant improvement.At 00:53 on (b)(6), the patient was transferred to icu for emergency treatment.
 
Event Description
It was reported that the patient underwent right ureteroscopic right ureteral lithotripsy on (b)(6) 2021, and a right ureteral stent was placed during the operation.On (b)(6) 2022, the right ureteral stent was removed by cystoscopy.The stent tube could not be pulled out after half of the stent tube was pulled out.The stent tube was found to have stones and floccules under the microscope, and the extubation was stopped, and the hospitalization procedures were completed.It was planned to sent the patient to the operating room for ureteral lithotripsy and stent removal.At 8:00 on (b)(6), the patient developed chills and high fever.The symptoms did not improve after anti-infective treatment and fluid replacement therapy, and the operation was suspended.At 17:54 on (b)(6), the patient developed septic shock.After active rescue and treatment, there was no significant improvement.At 00:53 on (b)(6), the patient was transferred to icu for emergency treatment.
 
Manufacturer Narrative
The reported event is inconclusive because no sample was returned for evaluation and further investigation was not conclusive.Based on the risk management file a potential root cause for this event could be, "material selection", however, there is not enough information in the event to confirm this cause.The device was used for treatment purposes.As the device was not returned for evaluation it is unknown if it had met all relevant specifications or resulted in the reported event.The device history record was reviewed and found nothing that could have caused or contributed to the reported event.The instructions for use were found adequate and state the following: "ureteral stents should be checked periodically for signs of encrustation and proper function.Periodic checks of the stent by cystoscopic and/or radiographic procedures are recommended at intervals deemed to be appropriate by the physician in consideration of the individual patient¿s condition and other patient specific factors.When long-term use is indicated, it is recommended that indwelling time not exceed 365 days.The stent is not intended as a permanent indwelling device." correction: b,g.H11: section a through f - the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.H3 other text : the device was not returned.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BARD® INLAY® URETERAL STENT
Type of Device
URETERAL STENT
Manufacturer (Section D)
C.R. BARD, INC. (COVINGTON) -1018233
8195 industrial blvd
covington 30014
Manufacturer (Section G)
C.R. BARD, INC. (COVINGTON) -1018233
8195 industrial blvd
covington 30014
Manufacturer Contact
juan velez
8195 industrial blvd
covington 30014
7707846100
MDR Report Key15293388
MDR Text Key298586451
Report Number1018233-2022-06655
Device Sequence Number1
Product Code FAD
UDI-Device Identifier00801741014765
UDI-Public(01)00801741014765
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
K983498
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 11/18/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number778426
Device Catalogue Number778426
Device Lot NumberNGFP0945
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/16/2022
Initial Date FDA Received08/25/2022
Supplement Dates Manufacturer Received11/18/2022
Supplement Dates FDA Received11/21/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/09/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age24 YR
Patient SexFemale
-
-